Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - AgileThought (NASDAQ:AGIL), Athersys (NASDAQ:ATHX)
Gainers
Source: benzinga.com
Page 9 - Athersys Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Athersys Inc Today - Breaking & Trending Today
Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios
The MOU includes $1.5M to $4.5M near term payments plus up to $150M in milestones ...
Source: marketscreener.com
Crude Oil Moves Lower; Neogen Posts Downbeat Results - Akero Therapeutics (NASDAQ:AKRO), Athersys (NASDAQ:ATHX)
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 175 points on Tuesday. The Dow traded up 0.53% to 33,781.59 while the NASDAQ rose 0.72% to 13,581.64. The S&P 500 also rose, gaining, 0.68% to 4,364.93.
Source: benzinga.com
S&P 500 Rises 1%; US Wholesale Inventories Fall In August - Akero Therapeutics (NASDAQ:AKRO), Athersys (NASDAQ:ATHX)
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Tuesday. The Dow traded up 0.81% to 33,876.62 while the NASDAQ rose 1.23% to 13,650.54. The S&P 500 also rose, gaining, 1.10% to 4,383.17.
Source: benzinga.com
Athersys Licenses its Animal Health Assets to Ardent Animal Health
CLEVELAND & LEXINGTON, Ky.--(BUSINESS WIRE)--Athersys, Inc. (Nasdaq: ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, and Multipotent Adult Progenitor Cell (MAPC®) technology for equine, canine, and feline health applications, announces the...
Source: pharmiweb.com